US$ 20.63
future glp-1 drugs Medications for Weight Loss: Semaglutide vs Tirzepatide vs Retat – Revolution Health & Wellness GLP-1 Users: Trends on Long-Term
Description
The percentage of participants experiencing vomiting is higher than what has been reported for the injectables, both in trials and real-world settings

19 Lofton H, Ard JD, Hunt RR, Knight MG

In 2022, the approval expanded to include adolescents aged 12 and older

Popular medications in this category include Semaglutide and Liraglutide

Most RCTs failed to demonstrate a significant association between GLP-1 RAs and the occurrence of pancreatitis or pancreatic cancer, primarily because of their short duration and insufficient design for evaluating such risks
